367 related articles for article (PubMed ID: 35135557)
1. CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis.
Mazzucco M; Mannheim W; Shetty SV; Linden JR
Fluids Barriers CNS; 2022 Feb; 19(1):13. PubMed ID: 35135557
[TBL] [Abstract][Full Text] [Related]
2. Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.
Brahmer A; Geiß C; Lygeraki A; Neuberger E; Tzaridis T; Nguyen TT; Luessi F; Régnier-Vigouroux A; Hartmann G; Simon P; Endres K; Bittner S; Reiners KS; Krämer-Albers EM
Cell Commun Signal; 2023 Oct; 21(1):276. PubMed ID: 37803478
[TBL] [Abstract][Full Text] [Related]
3. Differential Expression of Serum Extracellular Vesicle miRNAs in Multiple Sclerosis: Disease-Stage Specificity and Relevance to Pathophysiology.
Cuomo-Haymour N; Bergamini G; Russo G; Kulic L; Knuesel I; Martin R; Huss A; Tumani H; Otto M; Pryce CR
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163583
[TBL] [Abstract][Full Text] [Related]
4. Neurolymphatic biomarkers of brain endothelial inflammatory activation: Implications for multiple sclerosis diagnosis.
Yun JW; Cvek U; Kilgore PCSR; Tsunoda I; Omura S; Sato F; Zivadinov R; Ramanathan M; Minagar A; Alexander JS
Life Sci; 2019 Jul; 229():116-123. PubMed ID: 31082401
[TBL] [Abstract][Full Text] [Related]
5. Immuno-metabolic impact of the multiple sclerosis patients' sera on endothelial cells of the blood-brain barrier.
Sheikh MH; Henson SM; Loiola RA; Mercurio S; Colamatteo A; Maniscalco GT; De Rosa V; McArthur S; Solito E
J Neuroinflammation; 2020 May; 17(1):153. PubMed ID: 32386505
[TBL] [Abstract][Full Text] [Related]
6. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
7. Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis.
Koudriavtseva T; Stefanile A; Fiorelli M; Lapucci C; Lorenzano S; Zannino S; Conti L; D'Agosto G; Pimpinelli F; Di Domenico EG; Mandoj C; Giannarelli D; Donzelli S; Blandino G; Salvetti M; Inglese M
Front Immunol; 2020; 11():548604. PubMed ID: 33193314
[TBL] [Abstract][Full Text] [Related]
8. Cerebral microvascular endothelial cell-derived extracellular vesicles regulate blood - brain barrier function.
Hosseinkhani B; Duran G; Hoeks C; Hermans D; Schepers M; Baeten P; Poelmans J; Coenen B; Bekar K; Pintelon I; Timmermans JP; Vanmierlo T; Michiels L; Hellings N; Broux B
Fluids Barriers CNS; 2023 Dec; 20(1):95. PubMed ID: 38114994
[TBL] [Abstract][Full Text] [Related]
9. Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication.
Festoff BW; Li C; Woodhams B; Lynch S
J Neurol Sci; 2012 Dec; 323(1-2):61-5. PubMed ID: 22967748
[TBL] [Abstract][Full Text] [Related]
10. New Enhancing MRI Lesions Associate with IL-17, Neutrophil Degranulation and Integrin Microparticles: Multi-Omics Combined with Frequent MRI in Multiple Sclerosis.
Illes Z; Jørgensen MM; Bæk R; Bente LM; Lauridsen JT; Hyrlov KH; Aboo C; Baumbach J; Kacprowski T; Cotton F; Guttmann CRG; Stensballe A
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137391
[TBL] [Abstract][Full Text] [Related]
11. Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis.
Haschka D; Tymoszuk P; Bsteh G; Petzer V; Berek K; Theurl I; Berger T; Weiss G
Front Immunol; 2020; 11():594. PubMed ID: 32411125
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Plasma Using Flow Cytometry Reveals Increased Immune Cell-Derived Extracellular Vesicles in Untreated Relapsing-Remitting Multiple Sclerosis.
Blandford SN; Fudge NJ; Corkum CP; Moore CS
Front Immunol; 2022; 13():803921. PubMed ID: 35392085
[TBL] [Abstract][Full Text] [Related]
13. A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis.
Olsen JA; Kenna LA; Tipon RC; Spelios MG; Stecker MM; Akirav EM
EBioMedicine; 2016 Aug; 10():227-35. PubMed ID: 27381476
[TBL] [Abstract][Full Text] [Related]
14. The Validation Study of Neurofilament Heavy Chain and 8-hydroxy-2'-deoxyguanosine as Plasma Biomarkers of Clinical/Paraclinical Activity in First and Relapsing-Remitting Demyelination Acute Attacks.
Ljubisavljevic S; Stojanovic I; Basic J; Pavlovic DA
Neurotox Res; 2016 Oct; 30(3):530-8. PubMed ID: 27295058
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cytotoxic Eomes-expressing CD4
Raveney BJE; Sato W; Takewaki D; Zhang C; Kanazawa T; Lin Y; Okamoto T; Araki M; Kimura Y; Sato N; Sano T; Saito Y; Oki S; Yamamura T
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836594
[TBL] [Abstract][Full Text] [Related]
16. Myelin Basic Protein in Oligodendrocyte-Derived Extracellular Vesicles as a Diagnostic and Prognostic Biomarker in Multiple Sclerosis: A Pilot Study.
Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Picciolini S; Caputo D; Rovaris M; Pasanisi MB; Clerici M
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614334
[TBL] [Abstract][Full Text] [Related]
17. Rituximab for relapsing-remitting multiple sclerosis.
He D; Guo R; Zhang F; Zhang C; Dong S; Zhou H
Cochrane Database Syst Rev; 2013 Dec; (12):CD009130. PubMed ID: 24310855
[TBL] [Abstract][Full Text] [Related]
18. Plasma Interleukin-33 level in relapsing-remitting multiple sclerosis. Is it negatively correlated with central nervous system lesions in patients with mild disability?
Mado H; Adamczyk-Sowa M; Bartman W; Wierzbicki K; Tadeusiak B; Sowa P
Clin Neurol Neurosurg; 2021 Jul; 206():106700. PubMed ID: 34030079
[TBL] [Abstract][Full Text] [Related]
19. Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier.
Shimizu F; Tasaki A; Sano Y; Ju M; Nishihara H; Oishi M; Koga M; Kawai M; Kanda T
PLoS One; 2014; 9(3):e92872. PubMed ID: 24686948
[TBL] [Abstract][Full Text] [Related]
20. Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function.
Marcos-Ramiro B; Oliva Nacarino P; Serrano-Pertierra E; Blanco-Gelaz MA; Weksler BB; Romero IA; Couraud PO; Tuñón A; López-Larrea C; Millán J; Cernuda-Morollón E
BMC Neurosci; 2014 Sep; 15():110. PubMed ID: 25242463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
